China Pharma Holdings Income Statement (2010-2026) | CPHI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	2.42M	1.98M	2.89M	1.60M	1.61M	1.97M	2.92M	1.96M	1.10M	1.80M	2.15M	1.37M	0.92M	1.10M	1.13M	1.14M	1.03M	0.76M	1.23M	0.98M
Cost of Revenue (Quarter)	0.45M	2.28M	-5.21M	0.18M	0.27M	2.10M	2.88M	0.14M	1.24M	2.04M	0.26M	1.66M	0.11M	0.13M	0.17M	1.27M	0.10M	0.08M	4.01M	0.70M
Gross Profit (Quarter)	0.07M	-0.30M	0.30M	-0.17M	-0.23M	-0.14M	0.04M	0.18M	-0.15M	-0.23M	-0.08M	-0.29M	-1.02M	-0.52M	-0.16M	-0.14M	-0.09M	-0.06M	0.15M	0.29M
Operating items
Research & Development (Quarter)	0.05M	0.02M	0.05M	0.05M	0.02M	0.09M	0.03M	0.02M	0.02M	0.05M	0.15M	0.03M	0.16M	0.09M	547.00	0.03M	0.02M	0.04M	0.19M	0.08M
Selling, General & Administrative (Quarter)	0.33M	0.30M	0.61M	0.51M	0.27M	0.28M	0.83M	0.42M	0.11M	0.25M	0.69M	0.49M	0.09M	0.35M	0.86M	0.51M	0.44M	0.42M	1.08M	1.23M
Other Operating Expenses (Quarter)	0.44M	0.14M	0.29M	0.17M	0.26M	0.19M	0.35M	0.13M	0.17M	0.19M	0.27M	0.11M	0.12M	0.13M	0.18M	0.09M	0.10M	0.10M	0.08M	0.09M
Operating Expenses (Quarter)	0.82M	0.47M	0.95M	0.74M	0.55M	0.55M	1.21M	0.58M	0.31M	0.48M	1.11M	0.63M	0.38M	0.57M	1.04M	0.62M	0.57M	0.57M	1.35M	1.40M
Operating Income (Quarter)	-0.75M	-0.76M	-0.65M	-0.91M	-0.78M	-0.69M	-1.17M	-0.40M	-0.46M	-0.71M	-1.18M	-0.92M	-1.39M	-1.09M	-1.20M	-0.76M	-0.65M	-0.63M	-1.20M	-1.12M
EBIT (Quarter)	-0.75M	-0.76M	-0.65M	-0.91M	-0.78M	-0.69M	-1.17M	-0.40M	-0.46M	-0.71M	-1.18M	-0.92M	-1.39M	-1.09M	-1.20M	-0.76M	-0.65M	-0.63M	-1.20M	-1.12M
Non-operating items
Interest & Investment Income (Quarter)	579.00	638.00	0.00M	0.01M	0.00M	0.00M	0.00M	948.00	942.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	422.00	294.00	213.00	147.00
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	-0.07M	-0.06M	-0.33M	-0.12M	-0.11M	-0.10M	-0.10M	-0.08M	-0.14M	-0.06M	-0.05M	-0.04M	-0.05M	-0.03M	-0.03M	-0.03M	0.12M	-0.02M	-0.02M	-0.03M
Net income details
EBT (Quarter)	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M	-1.14M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-2.25M	-0.48M	-0.59M	-0.78M	-0.99M	-0.96M	-1.44M	-0.98M	-1.22M	-0.79M	-0.53M	-0.59M	-1.19M	-0.71M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M	-1.14M
Consolidated Net Income (Quarter)	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M	-1.14M
Income towards Parent Company (Quarter)	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M	-1.14M
Net Income towards Common Stockholders (Quarter)	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M	-1.14M
Additional items
EPS (Basic) (Quarter)	-9.05	-8.99	-10.63	-10.87	-9.16	-7.91	-12.02	-2.95	-2.99	-2.94	-3.64	-0.73	-0.89	-0.65	-0.70	-0.24	-0.16	-0.17	-0.28	-0.04
EPS (Diluted) (Quarter)	-9.46	-9.48	-11.25	-11.81	-10.19	-9.07	-14.50	-5.46	-6.80	-8.92	-14.14	-10.97	-16.50	-12.83	-14.05	-0.24	-0.16	-0.20	-0.37	-0.04
Shares Outstanding (Quarter)	0.09M	0.09M	0.09M	0.09M	0.10M	0.10M	0.11M	0.16M	0.20M	0.26M	0.34M	1.31M	1.61M	1.73M	1.75M	3.26M	3.26M	3.87M	4.29M	25.60M
Shares Outstanding (Diluted) (Quarter)	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	0.09M	3.26M	3.26M	3.26M	3.26M	25.60M
Shares Outstanding (Entity) (Quarter)	0.09M		0.09M	0.10M	0.10M			0.17M	0.17M	0.26M	0.34M
EBITDA (Quarter)	-0.75M	-0.76M	-0.65M	-0.91M	-0.78M	-0.69M	-1.17M	-0.40M	-0.46M	-0.71M	-1.18M	-0.92M	-1.39M	-1.09M	-1.20M	-0.76M	-0.65M	-0.63M	-1.20M	-1.12M
Interest Expenses (Quarter)	28.32M	28.41M	0.25M	0.22M	-0.04M	0.02M	0.05M	0.08M	0.14M	21.81M	-0.03M	0.02M	0.02M	0.02M		0.03M	0.02M	0.21M	0.05M	0.02M
Tax Rate (Quarter)

Research Tools

Developers

China Pharma Holdings Income Statement (2010-2026) | CPHI

Research Tools

Developers

China Pharma Holdings Income Statement (2010-2026) | CPHI

Create an account

Sign In

Reset Password